Portfolio management and program execution for 505b2 PE-backed fully integrated Global biopharma

Life sciences transaction advisory firmImpacted by Corporate RIF

Corporate Strategy Lead for fully-integrated biopharma on precipice of launching its 2nd product:- Led cross-functional teams to deliver LRP and corporate growth presentations for BoD; prepared market and indication outlooks, synthesized cross-functional input, and drove C-Suite alignment on key messaging- Identified inorganic growth opportunities and led due diligence assessments, including market research, forecasts (Sales, OpEx, P&L), and strategic fit evaluations; presented recommendations to Executive team- Coordinated bimonthly governance forums to support cross-functional alignment on key strategic initiativesImpacted by >40% RIF following CRL of vadadustat

Represented Commercial for pipeline and BD commercialization strategy, including: - New Product Planning: Supported +10 program teams (PC - POC) with Commercial input; researched voice of customer, developed product profiles, and led value analyses to guide clinical strategies; presented product vision, forecasts, and strategic recommendations at governance to inform Go-No-Go investment stage-gates- BD Due Diligence: Evaluated value and strategic fit of external BD targets, including +20 diligence assessments across +15 indications; analyses and recommendations presented to EC and BoD- Disease Area Strategy: Led cross-functional teams to deliver long-range disease area strategic plans; developed market overviews, segmentation, and outlooks, prioritized modalities and indications to maximize value, outlined investment scenarios and strategic stage-gates, and presented recommendations to EC - Portfolio Prioritization: Developed and socialized framework to evaluate disease area and indication favorability including descriptions of cross-functional input to support indication prioritization and investment exercises- Capability Leadership: Prepared playbook and led trainings on best practices and team accountabilities during POC readout and pivotal go-no-go decision points Focus Areas: Psychiatry (SCZ, TRD), Epilepsy, Ophthalmology, Immunology, Acute Neuro (Stroke, TBI), Pain, Digital Therapeutics and non-Neuro LCM across asset modalities (SM, LM, Cell & Gene Tx, Biosimilars)

Life sciences strategy consulting, including early-stage opportunity assessments across Oncology, Neurology/CNS, Hematology, and GI; analyzed competitive environments and clinical pipelines, interviewed KOLs and Payers to hypothesize utilization rates across major markets, designed forecast models and presented recommendations to inform commercialization and growth strategies

Life Sciences marketing & sales strategy consulting, including HCP/Patient market research, customer segmentation and experience design, patient services optimization, opportunity sizing, positioning, competitive landscape analysis, salesforce sizing alignment and training, product launch planning, and go-to-market strategyMember of Consumer & Patient Marketing, Behavioral & Cognitive Science, and Creative & Design teams

Life Sciences digital transformation consulting, including multi-channel marketing, launch planning, pricing strategy, and other commercial operations:- Oversaw design and roll-out of digital closed loop marketing tactics, including a tablet-based brochure that can be customized based on HCP preferences, leading to increased insight into customer-specific priorities- Evaluated fair market value of client portfolio focused on personalized in-pharmacy digital advertisements- Managed cross-functional implementation of a new digital platform to support marketing collateral reviews; identified team priorities and developed SOPs, KPI frameworks, and new-user training guides; led trainings- Developed thought leadership on multichannel closed loop marketing when supporting Integrated Health Networks

Led cross-functional team to source, evaluate and negotiate $100K convertible note investments for seed-stage start-ups; reviewed +125 pitches across life sciences, med device, diagnostics, digital and delivery; partnered with tech transfer office, presented recommendations to Advisory Board, managed portfolio co. relations

Envisioned novel health-coaching kiosk; developed business case, raised seed capital, and oversaw all aspects of product development, marketing, sales, and performance analytics